Pops, the leader in self-care solutions, is proud to announce the latest addition to its platform: Mina, a Virtual Health Assistant, which, in combination with new devices, will help people with diabetes manage their weight, blood pressure, and cholesterol levels. Alongside its revolutionary all-in-one glucose meter, Pops will now offer a cellular-connected blood pressure monitor and weight scale for its users, allowing them to track these vital health indicators through the Pops Rebel app.
Comorbidities such as high blood pressure, obesity, and high cholesterol are common among those with diabetes, with 14.7% of adults in the US estimated to have diabetes. According to the 2020 National Diabetes Statistics Report, 68% of adults with diabetes also have high blood pressure, 89% are overweight or obese, and 44% have high cholesterol.
“Mina motivates individuals to take charge of their overall health, empowered by their blood sugar, blood pressure, weight, and cholesterol data,” says Anna Christenson, Director of Product at Pops.
November is National Diabetes Month, a time to raise awareness of the impact of diabetes on millions of Americans. Without proper education, tools, and support, managing diabetes can be challenging, leading to serious complications, high healthcare costs, and even death. The total cost of diabetes in the US is a staggering $327 billion, and it is the seventh leading cause of death. The combination of diabetes and high blood pressure greatly increases the risk of heart disease and can cost over four times more than managing these conditions separately.
“At Pops, our mission is to help people Own Their Life®,” says Lonny Stormo, co-founder and CEO of Pops. “We are thrilled to expand our platform and empower people with diabetes to tackle their full metabolic health.”
Studies have shown that digital health solutions that include virtual coaching and self-monitoring with connected devices can significantly improve outcomes for those with chronic conditions. In January, Pops published a two-year clinical study in the International Journal of Digital Health, which demonstrated a sustained 1.3-point reduction in HbA1c among users of the Pops platform. With this expanded platform, Pops looks forward to sharing even more positive health outcomes in the future.